Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001178913-22-000169
Filing Date
2022-01-20
Accepted
2022-01-20 06:01:20
Documents
2
Group Members
KOBI GEORGE

Document Format Files

Seq Description Document Type Size
1 SC 13D zk2227076.htm SC 13D 58318
2 EXHIBIT 1 exhibit_1.htm EX-1 3433
  Complete submission text file 0001178913-22-000169.txt   63156
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86953 | Film No.: 22540554
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 KAFRISIN ST. TEL AVIV L3 6901658
Business Address
Mor George Adi (Filed by) CIK: 0001851069 (see all company filings)

Type: SC 13D